Menü
SeQuent® Please OTW features an optimized and clinically proven drug-coating technology which facilitates the safe and effective treatment of patients with peripheral arterial disease (PAD) in above and below the knee indications.
Controlled and effective drug dosage of Paclitaxel. Drug Dosage 3μg/mm2. Effective reduction of TLR compared to uncoated balloons Homogeneous coating even in the balloon folds exceeding distal and proximal markers
Resveratrol as hydrophilic excipient. Naturally occurring, plant-based substance acts as hydrophilic spacer and makes the Paclitaxel bioavailable. It enables controlled drug transfer into vessel wall
Technischer Prozedurerfolg durch einen knickresistenten Schaft und ein geringes Crossingprofil
